Batches of Ventolin Accuhaler and Seretide Accuhaler asthma inhalers recalled Three specific lots of asthma inhalers are being recalled, including preventer and emergency relief inhalers. People with asthma are being asked…
Read More
News Archive • Page 5 of 8 • Fortissa
(Generics (UK) Limited, trading as Mylan UK) A small number of packs from a specific batch may have an over count or under count of one tablet (EL (15)A/05). Class…
The Medicines and Healthcare products Regulatory Agency (MHRA) today (18 June) announced £15.8 million worth of counterfeit and unlicensed medicines and devices have been seized in the UK as part…
Class 3 medicines recall Action within 5 days Pharmacy-level recall MDR 13-04/15 Product details Allergan UK Limited Exocin 3mg/ml eye drops – Danish language packs only (Ofloxin) Alert details Allergan…
Class 2 medicines recall Action within 48 hours Pharmacy-level recall MDR 09-04/15 Product details RelonChem Ltd/ Kent Pharmaceuticals Tramadol 50mg capsules PL 20395/0065 Alert details RelonChem Ltd is recalling all…
Recall of all oral diclofenac presentations with legal status ‘P’ Novartis Consumer Health UK Limited (Diclofenac Potassium) Contact details Novartis products: All enquiries to Novartis Consumer Health Call Centre on 0800…
DRUG ALERT Class 2 medicines recall Action Within 48 Hours Hospital Pharmacy Level Recall Dear Healthcare Professional, Hospira UK Limited Mitoxantrone PL 04515/0127 Hospira UK Limited is recalling the above…
DRUG ALERT Class 2 medicines recall Action Within 48 Hours Pharmacy and Wholesaler Level Recall Dear Healthcare Professional, The Welcome Foundation Limited trading as GlaxoSmithKline UK Zovirax Eye Ointment (Aciclovir…
Class 2 medicines recall (action within 48 hours): Midazolam Buccal Liquid 10mg / 1ml, 5ml manufactured by Penn Pharma, distributed in Quantum Pharmaceutical livery. Penn Pharma, distributed in Quantum Pharmaceutical…
Reckitt Benckiser Healthcare (UK) Limited Fybogel Hi-Fibre (Ispaghula Husk) – PL 00063/0064 Fybogel Orange (Ispaghula Husk) – PL 00063/0026 Further to drug alert EL (14)A/04 issued 12 March 2014, Reckitt Benckiser Healthcare…